Aruvant Announces Oral Presentation at American Society of Gene and Cell Therapy (ASGCT)
/PRNewswire/ -- Aruvant Sciences ("Aruvant"), a private company focused on developing gene therapies for rare diseases, announced that data demonstrating the...
Stay updated with breaking news from Aruvant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Aruvant Sciences ("Aruvant"), a private company focused on developing gene therapies for rare diseases, announced that data demonstrating the...
/PRNewswire/ -- Aruvant Sciences ("Aruvant"), a private company focused on developing gene therapies for rare diseases, announced that the company will...
/PRNewswire/ -- Aruvant Sciences ("Aruvant"), a clinical-stage biopharmaceutical company focused on developing and commercializing transformative gene...
Press release content from PR Newswire. The AP news staff was not involved in its creation.
NEW YORK and BASEL, Switzerland, Jan. 20, 2022 /PRNewswire/ -- Aruvant, a clinical-stage biopharmaceutical company focused on developing and comme...